Pavan Battiprolu Email

VP . Poseida Therapeutics

Current Roles

Employees:
314
Revenue:
$46.3M
About
Poseida Therapeutics is translating best-in-class gene engineering technologies into lifesaving cell therapies. The company is developing CAR T-cell immunotherapies for multiple myeloma, prostate and other cancer types, as well as gene therapies for orphan diseases. P-BCMA-101 is Poseida's lead CAR-T therapy currently in Phase 1 clinical development for the treatment of multiple myeloma. Poseida has assembled a suite of industry-leading gene engineering technologies, including the piggyBac DNA Modification System, TAL-CLOVER and Cas-CLOVER site-specific nucleases, and Footprint-Free Gene Editing (FFGE). For more information, visit www.poseida.com.
Poseida Therapeutics Address
9390 Towne Centre Drive
San Diego, CA
United States
Poseida Therapeutics Email

Past Companies

Poseida Therapeutics, Inc.Executive Director, Head of Translation Medicine, Gene Therapy
Rocket PharmaceuticalsStrategic Consultant
Rocket PharmaceuticalsAssociate Vice President (Fellow)- Clinical Sciences (Cardiovascular AAV)

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.